Enhanced antiviral activity of acyclovir loaded into nanoparticles

Methods in Enzymology

Volumn 509, Issue , 2012, Pages 1-19

  Cavalli, Roberta ^a   Donalisio, Manuela ^a   Bisazza, Agnese ^a   Civra, Andrea ^a   Ranucci, Elisabetta ^b   Ferruti, Paolo ^b   Lembo, David ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Acyclovir; Antiviral activity; Biocompatibility assays; Cell internalization; Inclusion complex; Nanoparticles; Solvent displacement method; Cyclodextrin poly(4 acryloylmorpholine) monoconjugate

Indexed keywords

ACETONITRILE; ACICLOVIR; BETA CYCLODEXTRIN; BETA CYCLODEXTRIN POLY(4 ACRYLOYLMORPHOLINE) MONOCONJUGATE; COUMARIN; ESCULIN; NANOPARTICLE; POTASSIUM BROMIDE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CELL MIGRATION; CELL VIABILITY; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; DRUG SYNTHESIS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; NANOENCAPSULATION; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SKIN IRRITATION; VERO CELL; VIRUS INFECTIVITY; VIRUS TITRATION;

EID: 84860708211     PISSN: 00766879     EISSN: 15577988     Source Type: Book Series    
DOI: 10.1016/B978-0-12-391858-1.00001-0     Document Type: Chapter

References (22)

1. M. Beck-Broichsitter, E. Rytting, T. Lebhardt, X. Wang, and T. Kissel Preparation of nanoparticles by solvent displacement for drug delivery: A shift in the "ouzo region" upon drug loading Eur. J. Pharm. Sci. 41 2010 244 253
2. M. Bencini, E. Ranucci, P. Ferruti, A. Manfredi, F. Trotta, and R. Cavalli Poly (4-acryloylmorpholine) oligomers carrying a ß- cyclodextrin residue at one terminus J. Polym. Sci. A 46 2008 1607 1617 (Pubitemid 351310830)
3. R. Cavalli, F. Trotta, M.E. Carlotti, B. Possetti, and M. Trotta Nanoparticles derived from amphiphilic cyclodextrins J. Incl. Phenom. Macrocycl. Chem. 57 2007 657 661
4. R. Cavalli, M. Donalisio, A. Civra, P. Ferruti, E. Ranucci, F. Trotta, and D. Lembo Enhanced antiviral activity of acyclovir loaded into ß-cyclodextrin-poly(4-acryloylmorpholine)conjugate nanoparticles J. Control. Rel. 137 2009 116 122
5. M.D. Chavanpatil, A. Khdair, B. Gerard, C. Bachmeier, D.W. Miller, M.P. Shekhar, and J. Panyam Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug efflux Mol. Pharmacol. 4 2007 730 738 (Pubitemid 350004273)
6. J.S. Chawla, and M.M. Amiji Biodegradable poly(epsilon-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen Int. J. Pharm. 249 2002 127 138 (Pubitemid 35333439)
7. P. Collins, and D.J. Bauer Relative potencies of anti-herpes compounds Ann. N. Y. Acad. Sci. 284 1977 49 59
8. M.P. Desai, V. Labhasetawar, E. Walter, R.J. Levy, and G.L. Amidon The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent Pharm. Res. 14 1997 1568 1573 (Pubitemid 28009208)
9. H. Fessi, F. Puisieux, J.Ph. Devissaguet, N. Ammoury, and S. Benita Nanocapsule formation by interfacial polymer deposition following solvent displacement Int. J. Pharm. 55 1989 R1 R4
10. F. Ganachaud, and J.L. Katz Nanoparticles and nanocapsules created using the ouzo effect: Spontaneous emulsification as an alternative to ultrasonic and high-shear devices Chem. Phys. Chem. 6 2005 209 216 (Pubitemid 40379859)
11. O. Harush-Frenkel, N. Debotton, S. Benita, and Y. Altschuler Targeting of nanoparticles to the clathrin-mediated endocytic pathway Biochem. Biophys. Res. Commun. 353 2007 26 32 (Pubitemid 44958337)
12. S.K. Lai, K. Hida, S.T. Man, C. Chen, C. Machamer, T.A. Schroer, and J. Hanes Privileged delivery of polymer nanoparticles to the perinuclear region of live cells via a nonclathrin, non-degradative pathway Biomaterials 28 2007 2876 2884 (Pubitemid 46482662)
13. D. Lembo, and R. Cavalli Nanoparticulate delivery systems for antiviral drugs Antivir. Chem. Chemother. 21 2010 53 70
14. C.E. Mora-Huertas, H. Fessi, and A. Elaissari Influence of process and formulation parameters on the formation of submicron particles by solvent displacement and emulsification-diffusion methods: Critical comparison Adv. Colloid Interface Sci. 163 2011 90 122
15. J.J. O'Brien, and D.M. Campoli-Richards Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy Drugs 37 1989 233 309 (Pubitemid 19083613)
16. D. Quintanar-Guerrero, E. Allémann, H. Fessi, and E. Doelker Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers Drug Dev. Ind. Pharm. 24 1998 1113 1128 (Pubitemid 28546092)
17. B. Roizman, D.M. Knipe, and R.J. Whitley Herpes simplex viruses Fields Virology 5th edn. 2007 Lippincott Williams & Wilkins Philadelphia 2501 2601
18. A. Sahu, and J.D. Lambris Structure and biology of complement protein C3, a connecting link between innate and acquired immunity Immunol. Rev. 180 2001 35 48 (Pubitemid 32472850)
19. M.A. Schubert, and C.C. Müller-Goymann Solvent injection as a new approach for manufacturing lipid nanoparticles evaluation of the method and process parameters Eur. J. Pharm. Biopharm. 55 2003 125 131 (Pubitemid 36120504)
20. S. Verma, R. Gokhale, and D.J. Burgess A comparative study of top-down and bottom up approaches for the preparation of micro-nanosuspensions Int. J. Pharm. 380 2009 216 222
21. S.A. Vitale, and J.L. Katz Liquid droplet dispersions formed by homogeneous liquid-liquid nucleation: The Ouzo effect Langmuir 19 2003 4105 4110
22. A. Vonarbourg, C. Passirani, P. Saulnier, and J.P. Benoit Parameters influencing the stealthiness of colloidal drug delivery systems Biomaterials 27 2006 4356 4373 (Pubitemid 43674179)